The US dermal fillers market is estimated to grow at a CAGR of 7.1% during the forecast period. The US market is expected to reach around $2.7 billion in 2025 as compared to nearly $1.7 billion in 2018. This market growth owing to the rising demand for cosmetic procedures coupled with high consciousness about facial rejuvenation and an increasing number of medical spas in the region. A significant rise in cosmetic procedures was witnessed over the years in the US and Canada. For instance, as per the American Society of Plastic Surgeons (ASPS), there were 17.7 million surgical and minimally invasive cosmetic procedures performed in the US in 2018. Of which minimally invasive cosmetic procedures have significantly increased by nearly 228% since 2000. The demand for minimally invasive cosmetic procedures has grown significantly as compared to surgical procedures in the US. For instance, the number of cosmetic surgical procedures performed was nearly 1.8 million in 2018; however, the number of cosmetic minimally invasive procedures performed was nearly 15.9 million in 2018.
The US dermal fillers market can be segmented based on application, type, and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
Key players operating in the US dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market. For instance, in November 2018, Galderma Laboratories, L.P. received an FDA approval for ‘Restylane Lyft’, a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies.
Research Methodology
The market study of the US dermal fillers market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
1. US Dermal Fillers Market Research and Analysis by Application
2. US Dermal Fillers Market Research and Analysis by Type
3. US Dermal Fillers Market Research and Analysis by End-User
The Report Covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. US Dermal Fillers Market by Application
5.1.1. Face-Lift
5.1.2. Lip Treatment/Enhancement
5.1.3. Facial Line Correction Treatment
5.1.4. Others (Acne Scar Treatment)
5.2. US Dermal Fillers Market by Type
5.2.1. Collagen Fillers
5.2.2. Ploy-L-Lactic Acid (PLLA)
5.2.3. Hyaluronic Acid (HA)
5.2.4. Calcium Hydroxylapatite (CaHA)
5.2.5. Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
5.3. US Dermal Fillers Market by End-User
5.3.1. Dermatology Clinics
5.3.2. Hospitals
6. Company Profiles
6.1. Allergan PLC
6.2. Anika Therapeutics, Inc.
6.3. Croma-Pharma GmbH
6.4. Cynosure LLC
6.5. Galderma Laboratories, L.P.
6.6. Huons Co. Ltd.
6.7. Merz Pharmaceuticals GmbH
6.8. Prollenium Medical Technologies, Inc.
6.9. Sculpt Luxury Dermal Fillers Ltd.
6.10. Suneva Medical, Inc.
1. US DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. US DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
3. US DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. US DERMAL FILLERS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. US DERMAL FILLERS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
3. US DERMAL FILLERS MARKET SHARE BY END-USER, 2018 VS 2025 (%)